cropper
update
National Cannabis Newswire
update
  • Home
  • Categories
    • news
    • trends
    • insights
    • industry
    • legalization
    • health
    • culture
    • advocacy
    • Brands
    • New Mexico Dispensaries
    • Arizona Dispensaries
March 10.2026
2 Minutes Read

Patient Protect Launches to Empower UK Medical Cannabis Patients Facing Discrimination

Protesters holding signs, advocating for change, cloudy day.

Empowering Medical Cannabis Patients in the UK

The recent launch of Patient Protect is a promising development for medical cannabis patients facing discrimination in the UK. This initiative, spearheaded by patient advocate Alex Fraser and cannabis lawyer Robert Jappie, seeks to provide vital support by filling in the gaps left by government services. With systematic discrimination still prevalent, Patient Protect aims to offer guidance, advocacy, and a collaborative legal approach for patients dealing with various issues, including policing, employment, housing, and driving.

Building a Community of Support and Evidence

Patient Protect operates as a subscription service for medical cannabis clinics, ensuring access is scalable for both larger and smaller entities. Until March 31, clinics can subscribe to the service; thereafter, it will remain free for patients to report incidents. This long-awaited initiative is pivotal in creating a national evidence base that highlights the extent of discrimination in the UK medical cannabis space, as current reports indicate many patients still endure significant stigma and misunderstanding from authorities.

A Call for Systemic Change and Education

Fraser emphasizes the need for a trusted platform where patients can report their experiences. By collating these reports, Patient Protect can not only empower individuals but also advocate for systemic reform. The recent guidance issued by the National Police Chiefs’ Council, although not a comprehensive solution, marks the beginning of an educational effort necessary for improving outcomes for patients within law enforcement and beyond.

Addressing the Bigger Picture: Legal Access for All Patients

The UK medical cannabis scene still faces significant challenges, particularly regarding legal access for patients. According to a recent campaign led by the Medical Cannabis Clinicians Society, 1.8 million patients currently rely on the illicit market due to restrictions on GP prescribing. The demand for changes in policy allowing general practitioners to prescribe medical cannabis could drastically alter the landscape for patients, as highlighted by supporters of the Protect Our Patients campaign.

Conclusion: A Collective Effort for Change

As Patient Protect steps into this crucial role, it invites executive cannabis professionals to reflect on how they can contribute to this movement toward better support and understanding of medical cannabis patients. By working collaboratively and advocating for changes that prioritize patient needs, the community can support the positive momentum now gathering in the UK.

To stay informed about ongoing changes and how you can help advocate for patient rights, consider following Patient Protect and related initiatives advocating for systemic reform and better access within the medical cannabis domain.

Brands

28 Views

0 Comments

Write A Comment

*
*
Please complete the captcha to submit your comment.
Related Posts All Posts

Rescheduling Cannabis to Schedule III: What It Means for Industry Growth

Update A Historic Shift in Cannabis Policy The United States has taken a definitive step towards changing its approach to cannabis, announcing a transition from Schedule I to Schedule III classification under federal law. This pivotal decision, driven by President Trump’s executive order in December 2025, unlocks the potential for significant transformations within the cannabis industry, impacting everything from taxation to health care integration. The Meaning Behind Schedule III For decades, cannabis has been entangled in a web of regulatory constraints, classified alongside substances like heroin under Schedule I of the Controlled Substances Act. This status labeled it with no accepted medical use and a high potential for abuse. However, reclassifying cannabis as a Schedule III substance acknowledges its medicinal properties and significantly alters its place in drug policy. Impact on Cannabis Taxes and Business Operations One of the most immediate effects of this rescheduling is the alleviation of the burdensome Section 280E tax regulations. Currently, cannabis companies face tax rates reaching as high as 70%, as they cannot deduct standard business expenses. This change could pave the way for operators to reduce their tax liabilities and improve cash flow, enhancing their overall financial health and ability to reinvest in growth. A New Era for Medical Research and Insurance Rescheduling cannabis to Schedule III could ease the regulatory hurdles that have historically limited research on its health benefits. With easier access to study cannabis’ efficacy, a potential shift towards more standardized treatments could occur. This might also trigger pilot programs from federal health agencies exploring insurance coverage for medical cannabis, suggesting a pathway for broader acceptance of cannabis in mainstream health care. The Broader Implications of Cannabis Reform This move towards rescheduling isn't just an isolated change; it comes alongside other significant developments in the cannabis landscape. Institutions—and even banks—may now look more favorably on working with cannabis operators, improving access to capital and resources that have previously been elusive due to federal prohibitions. The anticipated flow of institutional investment could revitalize the sector, marking a turning point for budding companies. The Closing of the Hemp Loophole Simultaneously, another regulation banning intoxicating hemp-derived THC products exceeding 0.4mg per serving is set to come into effect in late 2026. While large multi-state operators may find favorable conditions through rescheduling, smaller hemp businesses that thrived on existing loopholes could face existential challenges. Looking Ahead: Cautious Optimism As the rescheduling process unfolds, it is vital for industry stakeholders to approach the future with both optimism and caution. While the change signifies progress, it doesn't legalize cannabis federally or resolve the need for further legislative reforms, particularly regarding banking. Stakeholders must navigate the complex landscape with a mindset geared towards adaptation and resilience. In this evolving landscape, operators, investors, and consumers must remain alert, leveraging opportunities while remaining aware of the remaining challenges. This historic shift marks not just a regulatory change, but also a maturation of the cannabis industry towards a more sustainable and integrated future.

Does the UK Media Represent Public Opinion on Cannabis? The Data Reveals Surprising Insights

Update The Disconnect Between Media Portrayal and Public Perception of Cannabis In recent discussions, a stark contrast has surfaced between how the UK media portrays cannabis and what the general public truly believes. A significant poll from YouGov, conducted between March 31 and April 1, 2026, involved over 2,000 participants and aimed to gauge the sentiments surrounding cannabis usage and legalization. The results are illuminating, revealing that more than a third of adults in Britain (37%) reported having used cannabis, yet the media's ongoing focus on the industry tends to skew perceptions away from this reality. Understanding Public Support for Cannabis Legalization When asked about their views on cannabis legalization, responses reflected a complex landscape of opinions. Approximately 47% of respondents supported legalization, while 43% opposed it. Notably, this divide becomes clearer when respondents were presented with three distinct pathways for cannabis: maintaining it as a criminal offense, decriminalizing it, or full legalization. The poll found that just over a third (35%) favored criminalization, with 33% advocating for legalization and 23% for decriminalization. Political Affiliations and Cannabis Sentiment The YouGov survey further highlighted how political affiliations significantly influence cannabis opinions. For instance, among Conservative voters, a striking 54% supported criminalization, whereas Labour and Liberal Democrat supporters showed more diverse views across all options. This trend demonstrates that public opinion on cannabis is not just a question of personal perception, but is also interwoven with the broader socio-political fabric of the UK. Patient Perspectives and the Medical Cannabis Debate Interestingly, a substantial majority of Britons (57%) perceive cannabis as harmful, with a notable distinction between cannabis and harder drugs. This suggests that while public sentiment remains cautious about cannabis, there is also an understanding of its different classifications within drug policy. Furthermore, 60% of participants believe that making cannabis illegal is ineffective at deterring usage—indicating a significant disconnect between the punitive approach and the realities of public behavior. Moving Towards a Balanced Discussion in Media Recent media narratives have painted a somewhat skewed view of cannabis, often highlighting sensational negative aspects, such as those articulated in recent articles that describe medical cannabis as a "shocking loophole." However, emerging voices like Charlotte Caldwell, who successfully campaigned for medical cannabis legality, now advocate for exploring regulated recreational use as a more comprehensive solution to what some deem a "broken cannabis policy." This evolving conversation suggests that there is room for a more balanced portrayal in the media—one that acknowledges both the risks and benefits of cannabis use. The YouGov data aligns with these changing dynamics, predominantly revealing that over half of the public (56%) would support some form of reforms to cannabis legislation. Conclusion: Bridging the Gap Between Perception and Public Awareness As we reflect on the current media's coverage of cannabis, it becomes crucial for industry professionals and advocates to pursue a dialogue that aligns with public sentiment. Promoting understanding and advocacy based on comprehensive research can significantly bridge the gap between media narratives and the public's evolving perception of cannabis in the UK. Executives and advocates within the cannabis industry must engage with these insights actively to inform their strategies moving forward, focusing on an evidence-based approach that resonates with public opinion, rather than allowing media narratives to dictate the discourse.

How South Africa’s Cannabis Industry is Paving the Path to Regulation

Update The Rise of a Thriving Cannabis Economy in South Africa Since the decriminalization of cannabis cultivation and possession in South Africa in 2018, the country has witnessed the organic growth of an industry that, according to government estimates, is already worth potentially R28 billion (about £1.28 billion). This burgeoning market, however, exists mostly in the shadows, with recent government initiatives aiming to shift the landscape towards a more structured and regulated framework. Charting the Course for Regulation In March 2026, the Portfolio Committee on Trade, Industry and Competition met to connect the dots within its National Cannabis Master Plan. This plan aspires to bring the existing cannabis market out of the shadows and into a legitimate, regulated economy. Ncumisa Mcata-Mhlauli, chief director at the Department of Trade, Industry and Competition, indicated that the government forecasts aggressive growth targets, aiming for a 10% annual increase in formal cannabis revenue from its current estimated R5.5 billion. However, disparities in figures reported by various stakeholders reveal an urgent need for clarity and cohesive strategy. Unlocking the Potential of the Legal Market Despite the current legal ambiguity, the cannabis market has thrived. According to legal strategist Charl Botha, the cannabis retail economy could be worth R9 to R10 billion annually, with significant activity occurring in unsanctioned spaces. Over 8,500 stores and 2,500 clubs operate throughout South Africa, indicating a deeply entrenched retail network that eagerly anticipates regulatory guidance. The challenge remains: how can the government best facilitate the transition of this already vital industry from the grey market into a taxable framework? The Complexity of Regulation and Consumer Needs The diversity of the cannabis market complicates regulation. Cannabis flower remains popular among consumers, while vapes, which command higher prices, capture urban interest. Edibles, although expanding the consumer base, introduce complications with dosing and measurement that make regulation more challenging. Moreover, current laws, such as Section 21 of the Medicines and Related Substances Act, allow limited access to cannabis for medical purposes, yet many retail outlets have attempted to operate under broader interpretations of this legislation. In Summary: A Market on the Verge of Transformation As South Africa navigates the future of its cannabis industry, it is clear that the market is ripe for transformation. The combination of its existing underground economy and the government's newfound focus could pave the way for a prosperous, legally regulated cannabis landscape. Cannabis professionals and enthusiasts alike must stay engaged as these developments unfold, ensuring they are a part of the conversation that shapes the future of this exciting industry. Call to Action: Stay informed on the evolving cannabis landscape in South Africa. Join the conversation and advocate for a fair and inclusive market to benefit all stakeholders.

Terms of Service

Privacy Policy

Core Modal Title

Sorry, no results found

You Might Find These Articles Interesting

T
Please Check Your Email
We Will Be Following Up Shortly
*
*
*